Todos Medical Ltd. Stock-Based Compensation
Todos Medical Ltd. reported Stock-Based Compensation of $2.75 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-11-14
- Todos Medical Ltd. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was $531.00K, a 126.92% increase year-over-year.
- Todos Medical Ltd. share-based payment arrangement, noncash expense for the quarter ending 2022-06-30 was $653.00K, a 298.17% increase year-over-year.
- Todos Medical Ltd. share-based payment arrangement, noncash expense for the quarter ending 2022-03-31 was $1.57M, a 567.23% increase year-over-year.
- Todos Medical Ltd. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $601.00K, a 116.19% increase year-over-year.
- Todos Medical Ltd. share-based payment arrangement, noncash expense for fiscal 2021 was $1.23M, a 52.76% decline from fiscal 2020.
- Todos Medical Ltd. share-based payment arrangement, noncash expense for fiscal 2020 was $2.61M, a 108.29% increase from fiscal 2019.
- Todos Medical Ltd. share-based payment arrangement, noncash expense for fiscal 2019 was $1.25M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2022-09-30 | $531.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.18M derived: sum of 2 quarters · filed 2022-11-14 | $2.75M 10-Q · filed 2022-11-14 | $3.35M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-06-30 | $653.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $2.22M 10-Q · filed 2022-08-22 | $2.82M derived: sum of 3 quarters · filed 2022-08-22 | $3.06M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2022-03-31 | $1.57M 10-Q · filed 2022-05-16 | $2.17M derived: sum of 2 quarters · filed 2022-05-16 | $2.40M derived: sum of 3 quarters · filed 2022-11-14 | $2.57M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-12-31 | $601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $835.00K derived: sum of 2 quarters · filed 2022-11-14 | $999.00K derived: sum of 3 quarters · filed 2022-11-14 | $1.23M 10-K · filed 2022-03-31 | |
| 2021-09-30 | $234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $398.00K derived: sum of 2 quarters · filed 2022-11-14 | $633.00K 10-Q · filed 2022-11-14 | $911.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $164.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $399.00K 10-Q · filed 2022-08-22 | $677.00K derived: sum of 3 quarters · filed 2022-08-22 | $1.19M derived: sum of 4 quarters · filed 2022-08-22 | |
| 2021-03-31 | $235.00K 10-Q · filed 2022-05-16 | $513.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.03M derived: sum of 3 quarters · filed 2022-05-16 | $2.02M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $278.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $794.00K derived: sum of 2 quarters · filed 2022-03-31 | $1.78M derived: sum of 3 quarters · filed 2022-03-31 | $2.61M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $516.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.50M derived: sum of 2 quarters · filed 2021-11-15 | $2.33M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24 | $1.82M 10-Q · filed 2021-09-24 | |||
| 2020-03-31 | $832.00K 10-Q · filed 2021-06-22 | ||||
| 2019-12-31 | $1.25M 10-K · filed 2021-04-21 | $1.25M 20-F · filed 2020-06-15 | |||
| 2018-12-31 | $47.67K 20-F/A · filed 2020-08-06 | ||||
| 2017-12-31 | $113.76K 20-F/A · filed 2020-08-06 | ||||
| 2016-12-31 | $210.18K 20-F · filed 2019-03-28 | ||||
| 2015-12-31 | $219.24K 20-F · filed 2018-05-15 | ||||
| 2014-12-31 | $0.00 20-F · filed 2017-05-01 |